Subashree Murugan

Subashree Murugan

Auto-generated profile, based on publicly available information

Subashree Murugan

Vision Science Program, School of Optometry, Indiana University Bloomington

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in Ophthalmology Science
Verified
Journal Article
Open access
RSRajalekshmy Shyam
Rajalekshmy Shyam
DODiego G. Ogando
Diego G. Ogando
EKEdward T. Kim
Edward T. Kim
SMSubashree Murugan
Subashree Murugan
MCMoonjung Choi
Moonjung Choi
JBJoseph A. Bonanno
Joseph A. Bonanno
Congenital hereditary endothelial dystrophy (CHED) is a rare condition that manifests at an early age showing corneal edema, increased oxidative stress, mitochondrial dysfunction, and eventually apoptosis of the endothelium due to loss of function of the membrane transport protein SLC4A11. This project tested whether replacing Slc4a11 into the Slc4a11-/- CHED mouse model can reverse the disease-associated phenotypes. Experimental study. Five-week-old or 11-week-old Slc4a11-/- mice. Age- and gender-matched Slc4a11+/+ animals were used as controls. A total of 124 animals (62 female, and 62 male) were used in this study. Fifty-three animals of the genotype Slc4a11+/+ were used as age- and gender-matched noninjected controls. Seventy-one Slc4a11-/- mice were administered anterior chamber injections of adeno-associated virus (AAV). Anterior chambers of young (5 weeks old) or older (11 weeks old) Slc4a11-/- mice were injected once with adeno-associated virus serotype 9 (AAV9) mouse Slc4a11 or AAV9-Null vectors. Corneal thickness was measured using OCT. End point analysis included corneal endothelial cell density, mitochondrial oxidative stress, and corneal lactate concentration. Corneal thickness, endothelial cell loss, lactate levels, and mitochondrial oxidative stress. In the young animals, AAV9-Slc4a11 reversed corneal edema, endothelial cell loss, mitochondrial oxidative stress, lactate transporter expression, and corneal lactate concentration to the levels observed in wild-type animals. In the older animals, gene replacement did not reverse the phenotype but prevented progression. Functional rescue of CHED phenotypes in the Slc4a11-/- mouse is possible; however, early intervention is critical.

14 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSubashree Murugan
Subashree Murugan
SGSachin Anil Ghag
Sachin Anil Ghag
VCViviane Souza de Campos
Viviane Souza de Campos
HPHsuan-Yeh Pan
Hsuan-Yeh Pan
MPMarianne Price
Marianne Price
RSRajalekshmy Shyam
Rajalekshmy Shyam
Fuchs Endothelial Corneal Dystrophy (FECD) is the irreversible degeneration of the corneal endothelium. The only treatment is corneal transplantation. To develop therapies for FECD, identifying the cellular causes for the onset and progression of the disease is crucial. While cell culture studies associate elevated oxidative stress, endoplasmic reticulum stress, endothelial-to-mesenchymal transition, and apoptosis with FECD, the causes behind the disease onset remain elusive. Guttae or Descemet’s membrane deposits are the earliest phenotype associated with FECD and are composed of unfolded proteins. Therefore, we asked if aberrant protein clearance pathways could be responsible for disease pathogenesis. We discovered a dysfunctional ubiquitin-proteasome pathway in a FECD mouse model and end-stage FECD patient samples. Inhibiting the ubiquitin-proteasome pathway in primary corneal endothelial cells resulted in the cellular dysfunctions associated with FECD. Finally, injecting healthy wild-type mice with proteasomal inhibitors resulted in all the major phenotypes associated with FECD, including corneal edema, guttae, and corneal endothelial cell loss. Therefore, this study strongly connects proteasomal dysfunction in FECD onset and progression.

6 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSubashree Murugan
Subashree Murugan
VCViviane Souza de Campos
Viviane Souza de Campos
SGSachin Anil Ghag
Sachin Anil Ghag
MNMatthew Ng
Matthew Ng
RSRajalekshmy Shyam
Rajalekshmy Shyam
Purpose: Fuchs Endothelial Corneal Dystrophy (FECD) is a progressive blinding disorder prevalent in 4% of Americans over 40. Corneal transplantation is the standard treatment. Animal models with partial FECD features exist, but a model encompassing all the major disease characteristics is desirable to improve the understanding of the pathogenesis and to identify signaling pathways involved in the disease onset and progression. Such an animal model can be helpful to develop intervention strategies. Here, we developed a mouse model that recapitulates all the features of FECD. Method: Loss of function mutations in Slc4a11 and a knock-in mutation in Col8a2 (Q455K) are implicated in FECD. Mice with Slc4a11 and Col8a2 mutations in C57BL/6J background were crossed to generate double mutant mice at F2 generation. At five weeks of age, a subset of the animals were fed tamoxifen-enriched chow or standard chow for two weeks, followed by standard chow. Corneal thickness, endothelial cell density, and guttae were measured at 5 (baseline) and 16 weeks of age. Corneas collected from mice at 16 weeks were stained for tight and adherens junctions, and reactive oxygen species. A lactate assay was performed to evaluate the endothelial pump function. Results: The double mutant tamoxifen-fed mice showed increased corneal thickness, decreased endothelial cell density, presence of guttae, and elevated stromal lactate levels. The endothelial cells showed altered morphology with disrupted adherens junctions and elevated ROS. Conclusion: Overall, this mouse model recapitulates all the important phenotypic features associated with FECD.

12 November 2026 in The American Journal of Pathology
Verified
Journal Article
Closed access
SGSachin Anil Ghag
Sachin Anil Ghag
HPHsuan-Yeh Pan
Hsuan-Yeh Pan
SGShreyasi Ganguly
Shreyasi Ganguly
VCViviane Souza de Campos
Viviane Souza de Campos
SMSubashree Murugan
Subashree Murugan
RSRajalekshmy Shyam
Rajalekshmy Shyam

8 November 2025 in bioRxiv
Verified
Preprint
Open access
SGSachin Anil Ghag
Sachin Anil Ghag
VCViviane Souza de Campos
Viviane Souza de Campos
SMSubashree Murugan
Subashree Murugan
SHSamuel Herberg
Samuel Herberg
RSRajalekshmy Shyam
Rajalekshmy Shyam
Purpose: Fuchs’ Endothelial Corneal Dystrophy (FECD), a degenerative corneal disorder, is marked by the thickening of Descemet’s membrane and a progressive loss of corneal endothelial cells, ultimately leading to vision loss. A feature associated with the disease is the reduced stiffness of Descemet’s membrane. However, the effects of this change in Descemet’s membrane, on corneal endothelial cell health are not well understood. To explore this, we used in vitro, in vivo, and ex vivo studies to investigate how changes in substrate stiffness and the signaling pathways associated with these changes influence corneal endothelial functions. Methods: For in-vitro studies, we cultured bovine corneal endothelial cells for 96 hours on stiff (32 kPa) and soft (8 kPa) substrate CytoSoft plates. By using Jess immunoassay and traditional western blotting, we evaluated changes in integrin signaling components, endothelial-to-mesenchymal transition, apoptosis, autophagy, and ubiquitin-proteasome pathway markers. Mitochondrial health and mitochondrial superoxide levels were assessed using commercial kits. We assessed the protein levels of the above-mentioned markers in the Col8a2 Q455K/Q455K FECD mouse model. To evaluate whether FAK signaling contributes to the FECD pathogenesis, we injected the Col8a2 Q455K/Q455K mice with an FAK inhibitor and assessed the corneal phenotypes. Results: We observed increased levels of phosphorylated FAK, integrins α4 and α5 in bovine corneal endothelial cells cultured on soft substrate. We also found upregulated endothelial-to-mesenchymal transition (EndMT) markers, mitochondrial dysfunction, and apoptosis in cells grown on soft substrate. In the Col8a2 Q455K/Q455K mouse model of FECD, there was increased pFAK Y397 levels coincident with the onset of phenotypes. Intraperitoneal injections of a pFAK inhibitor improved antioxidant protein expression and decreased EndMT; however, it did not improve FECD-associated disease progression. Conclusion: In this study, we explored how changes in the physical characteristics of the Descemet’s membrane impact corneal endothelial cell health. While we discovered activation of Focal adhesion kinase as a result of stiffness changes, its inhibition alone was insufficient to improve cell health in an FECD mouse model.